PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Agnieszka Korfel, MD
Charite-Universitaetsmedizin Berlin (Germany)
Principal Investigator - Daniela Bota, MD
Center101 The City Drive SouthOrange, CA 92686
Principal Investigator - Elisabeth Schorb, MD
UNIVERSITÄTSKLINIKUM FREIBURGKlinik für Innere Medizin I
Principal Investigator - Gerald Illerhaus, Prof
Klinik für Hämatologie, Onkologie und PalliativmedizinStuttgart Cancer
Principal Investigator - Martin Dreyling, Prof
Medizinische Klinik und Poliklinik III Klinikum der Universität München
Principal Investigator - Michael Weller, Prof
University of Zurich
Principal Investigator - Uwe Schlegel, Prof
Neurologische UniversitätsklinikKnappschaftskrankenhaus Bochum GmbH
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Nov 2015
- Primary completion
- 12 Jan 2018
- Completion
- 12 Jan 2018
- Last update posted
- 9 Jul 2019
- Registered enrollment
- 21
- Registry id
- NCT02669511
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.